The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats

Journal of Neurochemistry

Volumn 103, Issue 6, 2007, Pages 2505-2517

  Chiang, Yao Chang ^a   Chen, Jin Chung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Behavioral sensitization; Calcineurin; Cannabinoid type 1 receptor; Dopamine and cAMP regulated phosphoprotein of Mr 32 000; Methamphetamine; Nucleus accumbens

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 BROMOPHENYL) 1 (2,4 DICHLOROPHENYL) 4 ETHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; [5 (4 BROMOPHENYL) 1 (2,4 DICHLOROPHENYL) 4 ETHYL N (1 PIPERIDINYL) 1H PYRAZOLE 3 CARBOXAMIDE; CALCINEURIN; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; METHAMPHETAMINE; PHOSPHOPROTEIN DARPP 32; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SENSITIZATION;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BINDING, COMPETITIVE; CALCINEURIN; CYCLIC AMP; CYCLOHEXANOLS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; MALE; METHAMPHETAMINE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; RATTUS;

EID: 36448953926     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04981.x     Document Type: Article

References (59)

1. Andersson M., Usiello A., Borgkvist A. et al. (2005) Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J. Neurosci. 25, 8432 8438.
2. Anggadiredja K., Nakamichi M., Hiranita T., Tanaka H., Shoyama Y., Watanabe S. Yamamoto T. (2004) Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29, 1470 1478.
3. Basavarajappa B. S. Hungund B. L. (1999) Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res. 815, 89 97.
4. Basavarajappa B. S., Cooper T. B. Hungund B. L. (1998) Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res. 793, 212 218.
5. Cador M., Bjijou Y. Stinus L. (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65, 385 395.
6. Centonze D., Battista N., Rossi S., Mercuri N. B., Finazzi-Agro A., Bernardi G., Calabresi P. Maccarrone M. (2004) A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology 29, 1488 1497.
7. Cheer J. F., Wassum K. M., Sombers L. A., Heien M. L., Ariansen J. L., Aragona B. J., Phillips P. E. Wightman R. M. (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 27, 791 795.
8. Chen P. C. Chen J. C. (2005) Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 30, 538 549.
9. Chen P. C., Lao C. L. Chen J. C. (2007) Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization. J. Neurochem. 100, 225 241.
10. Chiang Y. C., Chen P. C. Chen J. C. (2003) D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine. Brain Res. 972, 159 167.
11. Colombo G., Serra S., Vacca G., Carai M. A. Gessa G. L. (2005) Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol. Biochem. Behav. 81, 369 380.
12. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G. A., Parmentier M. Fratta W. (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118, 61 65.
13. De Vries T. J., Shaham Y., Homberg J. R., Crombag H., Schuurman K., Dieben J., Vanderschuren L. J. Schoffelmeer A. N. (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat. Med. 7, 1151 1154.
14. Gerdeman G. Lovinger D. M. (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85, 468 471.
15. Glass M. Felder C. C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 5327 5333.
16. Gonzalez S., Fernandez-Ruiz J., Sparpaglione V., Parolaro D. Ramos J. A. (2002) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend. 66, 77 84.
17. Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024 1030.
18. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R. Rice K. C. (1990) Cannabinoid receptor localization in brain. Proc. Natl Acad. Sci. USA 87, 1932 1936.
19. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R. Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563 583.
20. Hermann H., Marsicano G. Lutz B. (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451 460.
21. Hoffman A. F. Lupica C. R. (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85, 72 83.
22. Hu X. T., Ford K. White F. J. (2005) Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology 30, 916 926.
23. Hyman S. E., Malenka R. C. Nestler E. J. (2006) Neural mechanism of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565 598.
24. Jarrahian A., Watts V. J. Barker E. L. (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J. Pharmacol. Exp. Ther. 308, 880 886.
25. Kalivas P. W. Stewart J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16, 223 244.
26. Kearn C. S., Blake-Palmer K., Daniel E., Mackie K. Glass M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 1697 1704.
27. Lecca D., Cacciapaglia F., Valentini V. Di Chiara G. (2006) Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration. Psychopharmacology (Berl), 188, 63 74.
28. Lesscher H. M., Hoogveld E., Burbach J. P., van Ree J. M. Gerrits M. A. (2005) Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol. 15, 31 37.
29. Lin X. H., Hashimoto T., Kitamura N., Murakami N., Shirakawa O. Maeda K. (2002) Decreased calcineurin and increased phosphothreonine-DARPP-32 in the striatum of rats behaviorally sensitized to methamphetamine. Synapse 44, 181 187.
30. Mailleux P. Vanderhaeghen J. J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48, 655 668.
31. Maldonado R., Valverde O. Berrendero F. (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29, 225 232.
32. Maneuf Y. P. Brotchie J. M. (1997) Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br. J. Pharmacol. 120, 1397 1398.
33. Mansuy I. M. (2003) Calcineurin in memory and bidirectional plasticity. Biochem. Biophys. Res. Commun. 311, 1195 1208.
34. Martin M., Ledent C., Parmentier M., Maldonado R. Valverde O. (2000) Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci. 12, 4038 4046.
35. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561 564.
36. Munro S., Thomas K. L. Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61 65.
37. Muschamp J. W. Siviy S. M. (2002) Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats. Pharmacol. Biochem. Behav. 73, 835 842.
38. Nairn A. C., Svenningsson P., Nishi A., Fisone G., Girault J. A. Greengard P. (2004) The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology 47 (Suppl 1 14 23.
39. Nishi A., Snyder G. L. Greengard P. (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147 8155.
40. Onaivi E. S., Leonard C. M., Ishiguro H., Zhang P. W., Lin Z., Akinshola B. E. Uhl G. R. (2002) Endocannabinoids and cannabinoid receptor genetics. Prog. Neurobiol. 66, 307 344.
41. Paxinos G. Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
42. Pickel V. M., Chan J., Kearn C. S. Mackie K. (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J. Comp. Neurol. 495, 299 313.
43. Pistis M., Ferraro L., Pira L., Flore G., Tanganelli S., Gessa G. L. Devoto P. (2002) Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 948, 155 158.
44. Price N. E. Mumby M. C. (1999) Brain protein serine/threonine phosphatases. Curr. Opin. Neurobiol. 9, 336 342.
45. Rinaldi-Carmona M., Barth F., Congy C. et al. (2004) SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyr azole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 310, 905 914.
46. Robbe D., Alonso G., Duchamp F., Bockaert J. Manzoni O. J. (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21, 109 116.
47. Rushlow W. J., Seah Y. H., Belliveau D. J. Rajakumar N. (2005) Changes in calcineurin expression induced in the rat brain by the administration of antipsychotics. J. Neurochem. 94, 587 596.
48. Segal D. S. Kuczenski R. (1997) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmacol. Exp. Ther. 282, 561 573.
49. Solinas M., Justinova Z., Goldberg S. R. Tanda G. (2006) Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J. Neurochem. 98, 408 419.
50. Soria G., Mendizabal V., Tourino C., Robledo P., Ledent C., Parmentier M., Maldonado R. Valverde O. (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30, 1670 1680.
51. Spano M. S., Fattore L., Cossu G., Deiana S., Fadda P. Fratta W. (2004) CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br. J. Pharmacol. 143, 343 350.
52. Vezina P. (2004) Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci. Biobehav. Rev. 27, 827 839.
53. Vigano D., Valenti M., Cascio M. G., Di Marzo V., Parolaro D. Rubino T. (2004) Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur. J. Neurosci. 20, 1849 1857.
54. Vinklerova J., Novakova J. Sulcova A. (2002) Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J. Psychopharmacol. 16, 139 143.
55. Wolf M. E. (2002) Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Interv. 2, 146 157.
56. Wolf M. E., White F. J., Nassar R., Brooderson R. J. Khansa M. R. (1993) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264, 249 255.
57. Xi Z. X., Gilbert J. G., Peng X. Q., Pak A. C., Li X. Gardner E. L. (2006) Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J. Neurosci. 26, 8531 8536.
58. Yao L., Fan P., Jiang Z., Mailliard W. S., Gordon A. S. Diamond I. (2003) Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc. Natl Acad. Sci. USA, 100, 14379 14384.
59. Yao L., McFarland K., Fan P., Jiang Z., Ueda T. Diamond I. (2006) Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc. Natl Acad. Sci. USA, 103, 7877 7882.